Microbot Medical to highlight LIBERTY Endovascular Robotic System full market release at Needham Conference

Microbot Medical Inc.

CEO Harel Gadot will present at the 25th Annual Needham Virtual Healthcare Conference on April 15, 2026 at 10:15 a.m. ET.
The LIBERTY Endovascular Robotic System is the only FDA-cleared, single-use, remotely operated robotic system for peripheral endovascular procedures.
Microbot completed the limited market release and commenced full market release of LIBERTY in the U.S. at the SIR Annual Scientific Meeting.
Senior executives will provide an overview of strategic positioning, growth opportunities, and market needs including physician radiation risks and physical strain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.